Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

First somatic mutation of E2F1 in a critical DNA binding residue discovered in well-differentiated papillary mesothelioma of the peritoneum.

Yu W, Chan-On W, Teo M, Ong CK, Cutcutache I, Allen GE, Wong B, Myint SS, Lim KH, Voorhoeve PM, Rozen S, Soo KC, Tan P, Teh BT.

Genome Biol. 2011 Sep 28;12(9):R96. doi: 10.1186/gb-2011-12-9-r96.

PMID:
21955916
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Heterozygous loss of NF2 is an early molecular alteration in well-differentiated papillary mesothelioma of the peritoneum.

Nemoto H, Tate G, Kishimoto K, Saito M, Shirahata A, Umemoto T, Matsubara T, Goto T, Mizukami H, Kigawa G, Mitsuya T, Hibi K.

Cancer Genet. 2012 Nov;205(11):594-8. doi: 10.1016/j.cancergen.2012.08.005. Epub 2012 Oct 2.

PMID:
23036697
[PubMed - indexed for MEDLINE]
3.

[Molecular regulation of KIR3DL1 gene expression by transcription factor E2F1].

Gao XN, Yu L.

Zhonghua Xue Ye Xue Za Zhi. 2008 Dec;29(12):806-10. Chinese.

PMID:
19176033
[PubMed - indexed for MEDLINE]
4.

Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.

Schayek H, Bentov I, Rotem I, Pasmanik-Chor M, Ginsberg D, Plymate SR, Werner H.

Growth Horm IGF Res. 2010 Feb;20(1):68-72. doi: 10.1016/j.ghir.2009.08.001. Epub 2009 Aug 22.

PMID:
19703789
[PubMed - indexed for MEDLINE]
5.

E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.

Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.

Oncogene. 2006 Jan 12;25(2):230-9.

PMID:
16158053
[PubMed - indexed for MEDLINE]
6.

Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.

Modi S, Kubo A, Oie H, Coxon AB, Rehmatulla A, Kaye FJ.

Oncogene. 2000 Sep 21;19(40):4632-9.

PMID:
11030152
[PubMed - indexed for MEDLINE]
Free Article
7.

YB-1, the E2F pathway, and regulation of tumor cell growth.

Lasham A, Samuel W, Cao H, Patel R, Mehta R, Stern JL, Reid G, Woolley AG, Miller LD, Black MA, Shelling AN, Print CG, Braithwaite AW.

J Natl Cancer Inst. 2012 Jan 18;104(2):133-46. doi: 10.1093/jnci/djr512. Epub 2011 Dec 28.

PMID:
22205655
[PubMed - indexed for MEDLINE]
Free Article
8.

p53-dependent down-regulation of telomerase is mediated by p21waf1.

Shats I, Milyavsky M, Tang X, Stambolsky P, Erez N, Brosh R, Kogan I, Braunstein I, Tzukerman M, Ginsberg D, Rotter V.

J Biol Chem. 2004 Dec 3;279(49):50976-85. Epub 2004 Sep 15.

PMID:
15371422
[PubMed - indexed for MEDLINE]
Free Article
9.

Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.

Zhou D, Masri S, Ye JJ, Chen S.

Gene. 2005 Nov 21;361:89-100. Epub 2005 Sep 21.

PMID:
16181749
[PubMed - indexed for MEDLINE]
10.

Direct repression of the human IRF-3 promoter by E2F1.

Xu HG, Ren W, Zou L, Wang Y, Jin R, Zhou GP.

Immunogenetics. 2011 Apr;63(4):189-96. doi: 10.1007/s00251-010-0505-5. Epub 2011 Jan 12.

PMID:
21225257
[PubMed - indexed for MEDLINE]
11.

Apoptosis signal-regulating kinase 1 is a direct target of E2F1 and contributes to histone deacetylase inhibitor-induced apoptosis through positive feedback regulation of E2F1 apoptotic activity.

Tan J, Zhuang L, Jiang X, Yang KK, Karuturi KM, Yu Q.

J Biol Chem. 2006 Apr 14;281(15):10508-15. Epub 2006 Feb 13.

PMID:
16476732
[PubMed - indexed for MEDLINE]
Free Article
12.

The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair.

Lin PS, McPherson LA, Chen AY, Sage J, Ford JM.

DNA Repair (Amst). 2009 Jul 4;8(7):795-802. doi: 10.1016/j.dnarep.2009.03.003. Epub 2009 Apr 18.

PMID:
19376752
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The human p73 promoter: characterization and identification of functional E2F binding sites.

Seelan RS, Irwin M, van der Stoop P, Qian C, Kaelin WG Jr, Liu W.

Neoplasia. 2002 May-Jun;4(3):195-203.

PMID:
11988839
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.

Alonso MM, Fueyo J, Shay JW, Aldape KD, Jiang H, Lee OH, Johnson DG, Xu J, Kondo Y, Kanzawa T, Kyo S, Bekele BN, Zhou X, Nigro J, McDonald JM, Yung WK, Gomez-Manzano C.

J Natl Cancer Inst. 2005 Nov 2;97(21):1589-600.

PMID:
16264179
[PubMed - indexed for MEDLINE]
Free Article
15.

Genome-wide analysis of transcription factor E2F1 mutant proteins reveals that N- and C-terminal protein interaction domains do not participate in targeting E2F1 to the human genome.

Cao AR, Rabinovich R, Xu M, Xu X, Jin VX, Farnham PJ.

J Biol Chem. 2011 Apr 8;286(14):11985-96. doi: 10.1074/jbc.M110.217158. Epub 2011 Feb 10.

PMID:
21310950
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

[Construction of a eukaryotic vector expressing E2F-1 Gene and its effect on proliferation of gastric cancer cell line MKN-45].

Wang CQ, Xiao Q, Li L, Xie YB, Tan N, Gong ZW.

Ai Zheng. 2007 Oct;26(10):1064-8. Chinese.

PMID:
17927874
[PubMed - indexed for MEDLINE]
17.

The E2F1 oncogene transcriptionally regulates NELL2 in cancer cells.

Kim DH, Roh YG, Lee HH, Lee SY, Kim SI, Lee BJ, Leem SH.

DNA Cell Biol. 2013 Sep;32(9):517-23. doi: 10.1089/dna.2013.1974. Epub 2013 Jul 5.

PMID:
23829315
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

p110 CUX1 cooperates with E2F transcription factors in the transcriptional activation of cell cycle-regulated genes.

Truscott M, Harada R, Vadnais C, Robert F, Nepveu A.

Mol Cell Biol. 2008 May;28(10):3127-38. doi: 10.1128/MCB.02089-07. Epub 2008 Mar 17.

PMID:
18347061
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance.

Engelmann D, PĆ¼tzer BM.

Drug Resist Updat. 2010 Aug-Oct;13(4-5):119-31. doi: 10.1016/j.drup.2010.06.001. Epub 2010 Aug 1. Review.

PMID:
20675184
[PubMed - indexed for MEDLINE]
20.

The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.

Jenal M, Trinh E, Britschgi C, Britschgi A, Roh V, Vorburger SA, Tobler A, Leprince D, Fey MF, Helin K, Tschan MP.

Mol Cancer Res. 2009 Jun;7(6):916-22. doi: 10.1158/1541-7786.MCR-08-0359. Epub 2009 Jun 2.

PMID:
19491197
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk